Published in Lab Business Week, August 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Akorn.
Report 1: Akorn, Inc. (NASDAQ: AKRX - News) and Cipla, Ltd., a leading Indian pharmaceutical company located in Mumbai, India, today announced the signing of an exclusive drug development and supply agreement for an oral ANDA drug product for the prevention of organ transplant rejection. According to 2006 IMS data, this drug product has a total market size of approximately $750 million for all indications.
Under the terms of the exclusive ten-year agreement, Cipla will be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.